Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-015778 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 7, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
24,702
Total Value
$185,529.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 2,631 | $3.79 | $9,970.96 | 342,023 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 2,631 | $18.73 | $49,288.63 | 339,392 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 5, 2026 | Exercise/Conversion | 1,786 | $3.79 | $6,768.58 | 341,178 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 5, 2026 | Sale | 1,786 | $18.74 | $33,464.10 | 339,392 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 3,817 | $3.79 | $14,465.67 | 343,209 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 6, 2026 | Sale | 3,817 | $18.75 | $71,571.80 | 339,392 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 2,631 | $0.00 | $0.00 | 233,476 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Exercise/Conversion | 1,786 | $0.00 | $0.00 | 231,690 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 6, 2026 | Exercise/Conversion | 3,817 | $0.00 | $0.00 | 227,873 | Direct | โ | View Details |